{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T21:03:57Z","timestamp":1784322237463,"version":"3.55.0"},"reference-count":10,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["journalofnuclearcardiology.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Nuclear Cardiology"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.nuclcard.2026.102764","type":"journal-article","created":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T20:18:12Z","timestamp":1781986692000},"page":"102764","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["124I-evuzamitide positron emission tomography\/computed tomography for rare types of cardiac amyloidosis: Expanding the molecular imaging frontier"],"prefix":"10.1016","volume":"60","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0022-4376","authenticated-orcid":false,"given":"Paco E.","family":"Bravo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hsiaoju Sharon","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan S.","family":"Wall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nuclcard.2026.102764_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.nuclcard.2026.102707","article-title":"Assessment of cardiac involvement in rare forms of amyloidosis using positron emission tomography\/computed tomography with 124I-evuzamitide (124I-p5+14, AT-01)","volume":"60","author":"Clerc","year":"2026","journal-title":"J Nucl Cardiol"},{"key":"10.1016\/j.nuclcard.2026.102764_bib2","doi-asserted-by":"crossref","first-page":"2404","DOI":"10.1161\/CIRCULATIONAHA.116.021612","article-title":"Nonbiopsy diagnosis of cardiac transthyretin amyloidosis","volume":"133","author":"Gillmore","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.nuclcard.2026.102764_bib3","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1007\/s11307-021-01681-2","article-title":"First in human evaluation and dosimetry calculations for peptide (124)I-p5+14-a novel radiotracer for the detection of systemic amyloidosis using PET\/CT imaging","volume":"24","author":"Wall","year":"2022","journal-title":"Mol Imag Biol"},{"key":"10.1016\/j.nuclcard.2026.102764_bib4","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1007\/s12350-016-0638-5","article-title":"Positron emission tomography (PET) utilizing Pittsburgh compound B (PIB) for detection of amyloid heart deposits in hereditary transthyretin amyloidosis (ATTR)","volume":"25","author":"Pilebro","year":"2018","journal-title":"J Nucl Cardiol"},{"key":"10.1016\/j.nuclcard.2026.102764_bib5","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1148\/radiol.2015141744","article-title":"Differential myocyte responses in patients with cardiac transthyretin amyloidosis and light-chain amyloidosis: a Cardiac MR Imaging Study","volume":"277","author":"Fontana","year":"2015","journal-title":"Radiology"},{"key":"10.1016\/j.nuclcard.2026.102764_bib6","doi-asserted-by":"crossref","DOI":"10.3390\/ph16040629","article-title":"Clinical confirmation of pan-amyloid reactivity of radioiodinated peptide (124)I-p5+14 (AT-01) in patients with diverse types of systemic amyloidosis demonstrated by PET\/CT imaging","volume":"16","author":"Martin","year":"2023","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.nuclcard.2026.102764_bib7","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1016\/j.jcmg.2023.07.007","article-title":"Cardiac amyloid quantification using (124)I-evuzamitide ((124)I-P5+14) versus (18)F-florbetapir: a Pilot PET\/CT Study","volume":"16","author":"Clerc","year":"2023","journal-title":"JACC Cardiovasc Imag"},{"key":"10.1016\/j.nuclcard.2026.102764_bib8","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1016\/j.jcmg.2023.08.009","article-title":"Cardiac amyloid detection by PET\/CT imaging of iodine ((124)I) evuzamitide ((124)I-p5+14): a Phase 1\/2 Study","volume":"16","author":"Wall","year":"2023","journal-title":"JACC Cardiovasc Imag"},{"key":"10.1016\/j.nuclcard.2026.102764_bib9","first-page":"807","article-title":"Development and evaluation of agents for targeting visceral amyloid","volume":"33","author":"Wall","year":"2011","journal-title":"Tijdschr Nucl Geneeskd"},{"key":"10.1016\/j.nuclcard.2026.102764_bib10","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0301756","article-title":"Preclinical evaluation of Tc-99m p5+14 peptide for SPECT detection of cardiac amyloidosis","volume":"19","author":"Kennel","year":"2024","journal-title":"PLoS One"}],"container-title":["Journal of Nuclear Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1071358126001455?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1071358126001455?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T20:18:35Z","timestamp":1784319515000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1071358126001455"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":10,"alternative-id":["S1071358126001455"],"URL":"https:\/\/doi.org\/10.1016\/j.nuclcard.2026.102764","relation":{},"ISSN":["1071-3581"],"issn-type":[{"value":"1071-3581","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"124I-evuzamitide positron emission tomography\/computed tomography for rare types of cardiac amyloidosis: Expanding the molecular imaging frontier","name":"articletitle","label":"Article Title"},{"value":"Journal of Nuclear Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nuclcard.2026.102764","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.nuclcard.2026.102707","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 American Society of Nuclear Cardiology. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"102764"}}